DEVELOPING UPPER LIMB MOTOR BIOMARKERS OF DEMENTIA
With
Kaylee Rudd,
Junior Research Fellow,
Wicking Dementia Research and Education Centre
University of Tasmania, Hobart, Tasmania
RESEARCHER PROFILE
Filmed in Hobart, Tasmania, Australia | February 2026
Kaylee is currently a research fellow with the Wicking Dementia Research and Education Centre at the University of Tasmania. She has recently submitted her PhD thesis, reporting the findings of her research on developing upper limb motor biomarkers of dementia. She has postgrad degrees in physiotherapy and experience working in the community and aged care across Tasmania for several years, where she worked with people with dementia.
Her experience underlined the importance of detecting cognitive impairment early and prompted her to join the Wicking to research dementia in 2021. Her research aims to better understand how movement is associated with cognition and to identify potential hand motor tests to help detect those at risk of developing cognitive impairment early.
One of the main highlights of her research experience has been close and regular collaboration with participants and team members of the ISLAND Clinic and the Tasmanian ISLAND Project.
Currently she coordinates the TapTalk project, a multi-level RHHRF funded project, which aims to develop a non-invasive screening test to detect risk of Alzheimer’s disease pathology.
Kaylee also contributes to national and international research projects. Examples are her work with the multisite Australian Dementia Network (ADNeT) study investigating the impact of blood-based biomarkers knowledge on clinician’s diagnostic confidence, and her ongoing collaboration with the AI-assisted motor biomarkers team in the University of Leeds, UK.
Collaborations and funding from
- Wicking Dementia research and Education Centre, University of Tasmania
- Royal Hobart Hospital, Tasmanian Health Service
- Royal Hobart Hospital Research Foundation (RHHRF)
Source: Supplied and adapted
https://orcid.org/0000-0002-8073-8691
-
Tyrosine Kinases in cancer recurrence
Dr Yu Yu leads the Oncology and Gynaecology Research Program at Curtin Medical Research Institute . Dr Yu is also a senior research fellow at Curtin Medical School.
Dr Yu Yu’s laboratory is working on better ways to treat cancers, particularly ovarian cancers which are resistant to conventional chemotherapy. The aims are for better informed treatment choice and reducing unnecessary exposure to ineffective chemotherapy and its potential adverse effects.
-
Trials in treating STIs, vaccines and lipid lowering medications
Since joining Paratus Clinical Research in 2022, Dr Pi Lip Seet has served as both Principal Investigator and Sub-Investigator across Phase I–IV industry-sponsored clinical trials. His research experience spans vaccines, immunology, cardiovascular and endocrine disease, respiratory medicine, gastroenterology, pain management, sleep medicine and adult psychiatry. He has been involved in multiple vaccine development programs, including RSV, influenza, COVID-19, herpes zoster and pneumococcal studies.
-
Mechanisms of resistance to menin inhibitor therapy and Acute Myeloid Leukaemia
Dr Rithin Nedumannil (MBBS, MPH, FRACP, FRCPA) is a PhD candidate at the University of Melbourne, undertaking his doctoral studies in collaboration with the Cambridge Stem Cell Institute (Cambridge, UK) and the Peter MacCallum Cancer Centre (Melbourne, Australia). He is a clinical haematologist and haematopathologist with current appointments at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, Austin Health and Northern Health.
